MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

University of Arkansas for Medical Sciences

University of Arkansas for Medical Sciences
Medical School - Teaching Hospital - Research Institution

The company in detail

Profile

The University of Arkansas for Medical Sciences (UAMS), the State's only comprehensive academic health center, consists of  five colleges including Medicine and Pharmacy, a graduate school of biomedical sciences, six centers of excellence, and a Statewide network of regional healthcare centers. UAMS was founded in 1879 as a proprietary medical school by a group of eight physicians with 22 students and today houses over 2,500 students, 1,156 physicians and 733 medical residents and is part of the University of Arkansas System. UAMS pursues its' three-fold mission -- to teach, to search, to serve -- through graduate and post graduate  programs in the various colleges.  National Institutes of Health and other federal funding sources actively support clinical and translational research programs within the University involving medical, device  and biotechnology research initiatives though programs in the University Hospital and its' affiliated clinics.   UAMS sponsors basic and clinical research in broad areas of medicine and medical therapy.  Traditionally strong research areas include Pharmacology and Toxicology; Cancer, Myeloma & Transplantation; Eye; Neuroscience; Pediatric Health; Aging & Gerontology and Psychiatry.  The proprietary technologies from this research are actively captured for licensing opportunities and the delivery of better health.  UAMS and its affiliates have an economic impact in Arkansas of over $5 billion a year.  UAMS BioVentures serves as the Technology Licensing Office, spin-out business accelerator, and the portal to all of the University's intellectual property and economic development programs. For more information, please visit www.uams.edu/bioventures or contact Michael G. Douglas, PhD mdouglas@uams.edu or Charlie Cook at (501) 686-6696 – e-mail CACook@uams.edu

Partnering strategy/interests

The University of Arkansas for Medical Sciences, through its TLO UAMS BioVentures, is seeking global, commercial partners to out-license its' technology for the purpose of taking its discoveries to the world's medical and healthcare market places.

Out-licensing

Acetaminophen-protein Adduct Dipstick: rapid, sensitive and specific diagnostic device for point-of-care determination of acetaminophen toxicity More
Acute Renal Failure Target - Calcium Independent Phospholipase A2 More
Overexpressed in Werner's Syndrome Fibroblasts More
Alzheimer's disease and other Neurodegenerative Conditions More
Customized laser skin treatment for superficial tumors, hair removal, Port-Wine Stain and other superficial vascular disorders. More
Prevention and novel treatment of cardiovascular conditions More
Cardiovascular physiology and atherosclerosis - prevention of cardiovascular complications in patients with renal failure or increased carbamylation. More
Protein Targeting, Hypoallergenic Food Development, and Allergy More
Novel agents capable of reaching remote cellular sites More
Derivatives of Butyric Acid and Uses Thereof - treatment of autoimmune More
An immunoassay for the detection of CA125 utilizing the monoclonal antibodies More
Tumor Biology - Therapeutic sequestering tumor cells growth and diagnostic as a tumor specific marker More
Antileukoprotease (ALP) is overexpressed in low malignant, potential tumors and carcinomas More
Transmembrane Serine Protease Overexpressed in Ovarian Carcinoma More
Novel Secreted Serine Protease (TADG-14) Overexpressed in Ovarian and Breast Cancer More
Adjuvant therapeutic approaches and targets to improve remission in breast and melanoma cancers More
Extracellular Serine Protease Overexpressed in Breast and Ovarian Carcinomas More
Diagnosis of functional heart disease and heart disease prognostication with emphasis on the multifractal alpha, the Levy flight analysis and the key discrete wavelet smoothing. More
Therapeutic agents for neurodegenerative disease, such as amyotrophic lateral sclerosis (ALS) More
An expression array diagnostic tool to predict survival in cancer patients, as well as, composition and methods to induce the predictive gene expression profile More
Activation of Raf-1/MEK-1/2/p42MAPK Alone Is Sufficient to Induce LDL Receptor Expression More
P38MAPK Inhibitor for Elevation of Hepatic LDL Receptor Levels More
Application: Colposcopy - Foot-operated Focusing Device for Floor Stand Mounted Instruments More
Improved efficiency and sensitivity for DNA analysis from formalin-fixed tissues and uses in kits for research and forensic pathology More
A unique cyclic (cold – heat) thermal ablation device for vastly improved performance and direct ablation of solid tumors. More
Molecular Cloning and Characterization of Cyclin G1 Binding Protein1 More
Treatment of Skin and Epithelial Tumors Using Intralesional Injection of Combined Antigens More
Improvements in anticancer treatments More
Potential to extend the development of vaccines against previous unavailable HPV viral types. More
Generation of new vaccines against rare epitopes of HPV to block viral infection and prevent cervical cancer. More
Preventative vaccine, source of antigens for dendritic cell immunotherapy to treat cervical cancer More
Dynamic treatment simulation software system for Intensity Modulated Radiation Therapy (IMRT) prior to the initiation of actual therapy More
An Endothelial lined Stent for Rapid Endothelialization and Preventing Restenosis More
Genetic cloning and sequencing of a novel IL-17 receptor-related gene More
Novel diagnostic and prognostic gene array classification system More
Non-primate animal model to several human infectious diseases More
Expression of Genes in Heterologous Hosts More
Diagnostic and/or Therapeutic Tool to modulate cell development and function More
Different myeloma tumor cell lines and their expansion for use in drug screening and research More
Use of Human Protein C for Intraocular Fibrin and Inflammation Prevention More
Method of Measuring by Gas Dilution Residual Lung Volume in Infants More
Growing mesenchymal stem cells that retain their undifferentiated properties More
Contrast agents for ultrasonic imaging, destruction of clots, ultrasound-induced permeability of blood vessels and other tissues, targeted drug delivery, or to enhance ultrasonic tissue ablation. More
precise and focused control of temperature mediated therapy and “triggering” deliverables in situ. More
Nutritional intervention to abrogate the adverse effects in diabetes-related pregnancy More
Metabolomic assessment of the different Cytochrome P450 and UDP-Glucuronosyltransferase contributions to Warfarin Metabolism in individual patients More
Analytical methods for screening new drug candidates More
identifying and quantifying specific HAT activity at the lysine being targeted by the HAT for covalent modification More
Specific therapeutic target on platelets for blocking inflammatory diseases of the joint: “collagen microparticle footprint” More
Rapidly (less than 24 hours) diagnose MOTT infections in humans or animals More
In-home device to induce cycling motion in patients who have little or no motor control of their legs - increasing muscle mass and decreasing hyperreflexia More
Laser Directed Portable MRI Stereotactic System More
Application: Safer and More Efficient Gene Therapies More
Biomimic prenatal and postnatal maternal-to-infant transfer of clinical monosaccharides for improved neurologic development and immunologic functions More
A novel and simplified methodology for growth and analysis of biofunctions with applications in the fields of pharmocogenomics and neurodevelopment and neurotoxicology. More
Novel nonpalpable lesion detection procedure using hematoma - directed ultrasound and imaging. More
Gene and/or protein therapy for Hepatitis C infection More
Novel method to quantify polymorphisms in electropherograms, a new approach to the identification of ambiguous DNA sequence reads and its automation More
Regulation of key transcriptional elements in the development and aging of heart muscle More
Surgical device, a catheter that enables a connection between the pancreatic duct and small bowel. More
Abdominal surgical closure device More
Proprietary polymer can be used to form tumors of various consistencies in cadaveric platforms for surgical training More
Thalidomide has been successfully used to successfully treat myeloma patients however, patients with high IL6R expression levels via gene expression profiling, do not benefit from the use of this drug. Therefore, the use of anti-IL6R therapies in combina More
drug delivery - a novel and effective method for the microencapsulation of small peptides that allows their use and controlled release over a time frame of several months. More
Cancer treatment, including vaccines, targets for immune stipulation, drug, or biological modifier delivery More
Computerized decision making information system to direct the orders for patients sustaining multiple rib fractures. More
Gene array analysis and genetic testing uncovering a TP53 genetic deletion in multiple myeloma patients in combination with the use of risk-adapted therapy that incorporates thalidomide with bortezomib vastly improves patent outcomes. More
when used in combination with other drugs these UGT inhibitors act to significantly enhance efficacy antiviral therapeutics that require UGT's for their systemic clearance. More
Ref: Molecular Microbiology (1999) 33, 1, 307-316 More
Ovarian cancer immunotherapy - therapeutic vaccine More
Screening tool for the detection of breast and other cancers More
Method for Reducing Radiation Toxicity More
Mycobacterium Specific Tuberculosis Diagnostic Testing More
Cancer - Novel Cell Surface Proteolytic Activity (Proteases) in Carcinogenic Tissues More
Accurate placement of catheter needles More
Compositions and methods for targeted therapeutic release of encapsulated materials from multi functional liposomes at the site of a solid tumor or a diseased site using ionizing and non-ionizing radiation, a process called conformal Intensity Modulated R More
A multi-faceted invention that has identified novel compositions that may be useful for pharmacological, diagnostic and research development for more effective pain control. An in vitro enzymatic process that produces novel glucuronyl derivatives of canna More
Exogenous Type IV Collagen and combinations promote recovery of cellular function following sublethal toxic injury and renal disease More
Method of use for a visualization agent to distinguish and visualize bone and soft mastoid tissues due to inflammation when performing skull based surgeries or similar procedures More
Novel Surgical Clips for Vascular Bypass and Tissue Grafts for Vascular surgery, vascular grafts, sutureless anastomosis and bypass surgery More
Transplantation animal to human, organs, tissues, and cells. More

Deals

To view this information, you must subscribe to PL Intelligence.

Press Releases

(13th Feb 2008) Little Rock Medical Technology Expo scheduled for October 2008 More
(12th Jul 2007) BioTechnology Task Force makes key gains with Tech Parks and Association Support More
(12th May 2007) Agreement would facilitate for vaccine development More
More press releases

Contact details

Mr. Charles Cook
Licensing Associate
UAMS BioVentures - TLO

Contact directly

Full contact list

Head office

University of Arkansas for Medical Sciences
UAMS BioVentures
Technology Licensing Office
4301 West Markham Street #831
Little Rock
Arkansas
72205-7199
Arkansas

Company figures

Formed: 1879
Number of employees: 9600

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us